Stem cells are unspecialized cells that can develop into any type of cell in the body. This ability is essential for embryonic development and tissue repair, but it also means that stem cells can become cancerous if they don't receive the right signals.
The UCSF team found that stem cells use a "molecular switch" to decide whether to become a specific type of cell or remain a stem cell. This switch is controlled by a protein called Oct4, which is found in high levels in stem cells. When Oct4 levels drop, the stem cell begins to differentiate into a specific type of cell.
The researchers also found that they could control the fate of stem cells by manipulating Oct4 levels. By increasing Oct4 levels, they could keep stem cells in an undifferentiated state. By decreasing Oct4 levels, they could prompt stem cells to differentiate into specific types of cells.
This discovery could have a major impact on regenerative medicine, which aims to use stem cells to repair damaged tissues. By controlling the fate of stem cells, researchers could potentially grow new tissue to replace damaged or diseased tissue.
The discovery could also have implications for cancer treatment. Many cancers are caused by stem cells that have lost their ability to differentiate into specific types of cells. By understanding how stem cells choose their identity, researchers could develop new drugs that target this process and prevent cancer cells from growing.
The UCSF team's findings were published in the journal Nature.
